• Reference Citation Analysis
  • v
  • v
  • Find an Article
  • Find an Author
Download
Number Citation Analysis
1
Katsiki N, Filippatos T, Vlachopoulos C, Panagiotakos D, Milionis H, Tselepis A, Garoufi A, Rallidis L, Richter D, Nomikos T, Kolovou G, Kypreos K, Chrysohoou C, Tziomalos K, Skoumas I, Koutagiar I, Attilakos A, Papagianni M, Boutari C, Kotsis V, Pitsavos C, Elisaf M, Tsioufis K, Liberopoulos E. Executive summary of the Hellenic Atherosclerosis Society guidelines for the diagnosis and treatment of dyslipidemias - 2023. Atheroscler Plus 2024;55:74-92. [PMID: 38425675 PMCID: PMC10901915 DOI: 10.1016/j.athplu.2024.01.004] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 08/23/2023] [Revised: 12/20/2023] [Accepted: 01/29/2024] [Indexed: 03/02/2024]
2
Papakitsou I, Petrakis E, Vougiouklakis G, Mavrikaki V, Spentzouri D, Tzalis S, Bargodakis M, Vasilopoulos K, Tsiavos A, Zagaliotis A, Ioannou P, Filippatos T. Antidiabetic treatment in elderly patients with low performance status admitted to internal medicine ward. Atherosclerosis 2022. [DOI: 10.1016/j.atherosclerosis.2022.06.594] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
3
Barkas F, Elisaf M, Filippatos T, Ntekouan SF, Sakkas N, Liberopoulos E. Lipid And Glycemic Profile Of Overweight And Obese Patients. Atherosclerosis 2019. [DOI: 10.1016/j.atherosclerosis.2019.06.395] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
4
Barkas F, Pappa E, Liberopoulos E, Filippatos T, Florentin M, Christopoulou F, Elisaf M, Liamis G. Lipid target attainment in a specialized lipid clinic. Atherosclerosis 2018. [DOI: 10.1016/j.atherosclerosis.2018.06.251] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
5
Filippatos T, Tsimihodimos V, Derdemezis C, Gazi I, Saougos V, Tselepis A, Elisaf M. 543 PLASMA VISFATIN CONCENTRATION IS A MARKER OF AN ATHEROGENIC METABOLIC PROFILE. ATHEROSCLEROSIS SUPP 2011. [DOI: 10.1016/s1567-5688(11)70544-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
6
Nakou E, Filippatos T, Kostara C, Agouridis A, Bairaktari E, Elisaf M. P276 THE EFFECTS OF EZETIMIBE, ALONE OR COMBINED WITH ORLISTAT, ON TRIGLYCERIDE-RICH LIPOPROTEIN METABOLISM IN OVERWEIGHT AND OBESE PATIENTS WITH HYPERLIPIDAEMIA. ATHEROSCLEROSIS SUPP 2010. [DOI: 10.1016/s1567-5688(10)70343-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
7
Nakou E, Filippatos T, Kiortsis D, Derdemezis C, Georgoula M, Petraki M, Tselepis A, Elisaf M. Abstract: P956 THE EFFECTS OF EZETIMIBE AND ORLISTAT, ALONE OR IN COMBINATION, ON HIGH DENSITY LIPOPROTEIN (HDL) SUBCLASSES AND HDL-ASSOCIATED ENZYME ACTIVITIES IN OVERWEIGHT AND OBESE PATIENTS WITH HYPERLIPIDAEMIA. ATHEROSCLEROSIS SUPP 2009. [DOI: 10.1016/s1567-5688(09)71077-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
8
Filippatos T, Tsimihodimos V, Kostapanos M, Kostara C, Tzallas C, Bairaktari E, Tselepis A, Elisaf M. Abstract: P933 APOLIPOPROTEINS C-II AND C-III AND SMALL DENSE LDL CHOLESTEROL LEVELS IN NON-DIABETIC OBESE SUBJECTS WITH METABOLIC SYNDROME. ATHEROSCLEROSIS SUPP 2009. [DOI: 10.1016/s1567-5688(09)71054-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
9
Filippatos T, Mikhailidis D. Lipid-Lowering Drugs Acting at the Level of the Gastrointestinal Tract. Curr Pharm Des 2009;15:490-516. [DOI: 10.2174/138161209787315738] [Citation(s) in RCA: 40] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
10
Lagos K, Gazi I, Kostapanos M, Filippatos T, Kazakou P, Rizos C, Tselepis A, Elisaf M. HIGH-DENSITY LIPOPROTEIN SUBCLASSES IN PATIENTS WITH OR WITHOUT THE METABOLIC SYNDROME. ATHEROSCLEROSIS SUPP 2008. [DOI: 10.1016/s1567-5688(08)70510-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
11
Kostapanos M, Filippatos T, Milionis H, Kostara C, Bairaktari E, Elisaf M. Th-P16:404 Effect of rosuvastatin on apolipoprotein CII and CIII serum levels in patients with primary dyslipidemia. ATHEROSCLEROSIS SUPP 2006. [DOI: 10.1016/s1567-5688(06)82362-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
12
Gazi I, Lourida E, Filippatos T, Tsimihodimos V, Saougos V, Elisaf M, Tselepis A. Th-P15:49 Lipoprotein-associated phospholipase A2 activity (LP-PLA2) is a marker of small-dense LDL particles. ATHEROSCLEROSIS SUPP 2006. [DOI: 10.1016/s1567-5688(06)82009-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
13
Gazi I, Filippatos T, Bairaktari E, Kostara C, Tselepis A, Elisaf M. We-P11:104 LDL subfractions in patients with metabolic syndrome. ATHEROSCLEROSIS SUPP 2006. [DOI: 10.1016/s1567-5688(06)81458-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
14
Milionis H, Rizos E, Kostapanos M, Filippatos T, Goudevenos J, Mikhailidis D, Elisaf M. Th-P16:381 Treating to target patients with primary hyperlipidemia: Comparison of the effects of atorvastatin and rosuvastatin (The atoros study). ATHEROSCLEROSIS SUPP 2006. [DOI: 10.1016/s1567-5688(06)82339-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
15
Kostapanos M, Filippatos T, Gazi I, Milionis H, Tselepis A, Elisaf M. Th-P15:33 Effect of rosuvastatin on low density lipoprotein (LDL) concentration and relative distribution in patients with primary dyslipidaemia. ATHEROSCLEROSIS SUPP 2006. [DOI: 10.1016/s1567-5688(06)81993-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
PrevPage 1 of 1 1Next
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA